As Insurers Drop GLP-1 Coverage, Advocates Search for a Hero in Obesity
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.
The combined organization would serve nearly 2.4 million members in Massachusetts, Maine, Connecticut, New Hampshire and Rhode Island.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.